Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 138 M127 M134 M130 M149 M141 M 554 M Research & development —————— — Operating income 624 M427 M619 M704 M412 M458 M 2.19 B Non-Operating Income, Total -197 M-197 M-206 M-224 M-223 M217 M -436 M Interest expense, net of interest capitalized 250 M256 M271 M279 M293 M301 M 1.14 B Non-Operating Income, excl. Interest Expenses -447 M-453 M-477 M-503 M-516 M-135 M -1.63 B Unusual income/expense 30 M34 M39 M26 M39 M51 M 155 M Pretax income 427 M230 M413 M480 M189 M241 M 1.32 B Equity in earnings 7 M4 M5 M31 M3 M4 M 43 M Taxes -18 M1 M-6 M111 M-58 M41 M 88 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 445 M229 M419 M369 M247 M282 M 1.32 B Discontinued operations —————— — Net income 445 M229 M419 M369 M247 M282 M 1.32 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 444 M228 M418 M369 M247 M280 M 1.31 B Basic earnings per share (Basic EPS) 2.141.12.021.781.191.35 6.34 Diluted earnings per share (Diluted EPS) 2.141.12.011.781.191.35 6.33 Average basic shares outstanding 207 M207 M207 M207 M207 M208 M — Diluted shares outstanding 207 M207 M207 M207 M208 M208 M — EBITDA 1.08 B878 M1.08 B1.18 B895 M— — EBIT 624 M427 M619 M704 M412 M458 M 2.19 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 452 M451 M464 M474 M483 M— —